Darrell R. Borger
Mochida Pharmaceutical (Japan)(JP)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research
Most-Cited Works
- → Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping(2011)707 cited
- → RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer(2015)626 cited
- → Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine(2010)397 cited
- → Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice(2011)367 cited
- → Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer(2010)330 cited
- → BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications(2011)308 cited
- → Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma(2020)294 cited
- → Phase 1/2 study of everolimus in advanced hepatocellular carcinoma(2011)195 cited
- → Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH -Mutant Gliomas(2014)192 cited
- → A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer(2011)176 cited